121 related articles for article (PubMed ID: 35641667)
1. Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma.
Yanai Y; Hayashi T; Tsuyama S; Nasu M; Hashimoto T; Kajiyama Y; Tsurumaru M; Mine S; Orita H; Fukunaga T; Yao T; Saito T
Virchows Arch; 2022 Sep; 481(3):477-487. PubMed ID: 35641667
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis of clinicopathological factors and survival between esophageal basaloid squamous cell carcinoma and conventional esophageal squamous cell carcinoma.
Jiang D; Wang H; Deng M; Song Q; Liu Y; Peng R; Xu L; Su J; Xu C; Hou Y
Eur J Surg Oncol; 2023 May; 49(5):958-963. PubMed ID: 36588005
[TBL] [Abstract][Full Text] [Related]
3. TP53 Mutations in Esophageal Squamous Cell Carcinoma.
Zhong L; Li H; Chang W; Ao Y; Wen Z; Chen Y
Front Biosci (Landmark Ed); 2023 Sep; 28(9):219. PubMed ID: 37796679
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression.
Sato-Kuwabara Y; Fregnani JH; Jampietro J; Carvalho KC; Franco CP; da Costa WL; Coimbra FJ; Soares FA
Tumour Biol; 2016 May; 37(5):6691-9. PubMed ID: 26649862
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
[TBL] [Abstract][Full Text] [Related]
7. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
8. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
[TBL] [Abstract][Full Text] [Related]
9. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
10. Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma.
Lin CS; Wang LS; Chang SC; Chou TY; Hsu WH; Liu CS; Lee MH; Chung MY; Wei YH
Oncol Rep; 2012 Jul; 28(1):69-76. PubMed ID: 22505350
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Clinicopathological Characteristics and Prognosis of Esophageal Squamous Cell Carcinoma with Intramural Metastases and Multiple Primary Carcinomas.
Cheng N; Li W; Wang B; Li Z; Yang Z; Chen R; Xue L
World J Surg; 2023 Mar; 47(3):707-716. PubMed ID: 36437350
[TBL] [Abstract][Full Text] [Related]
12. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
[TBL] [Abstract][Full Text] [Related]
13. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
14. Profile of esophageal squamous cell carcinoma mutations in Brazilian patients.
Munari FF; Dos Santos W; Evangelista AF; Carvalho AC; Pastrez PA; Bugatti D; Wohnrath DR; Scapulatempo-Neto C; Guimarães DP; Longatto-Filho A; Reis RM
Sci Rep; 2021 Oct; 11(1):20596. PubMed ID: 34663841
[TBL] [Abstract][Full Text] [Related]
15. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
17. Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing.
Chen XX; Zhong Q; Liu Y; Yan SM; Chen ZH; Jin SZ; Xia TL; Li RY; Zhou AJ; Su Z; Huang YH; Huang QT; Huang LY; Zhang X; Zhao YN; Yun JP; Wu QL; Lin DX; Bai F; Zeng MS
Nat Commun; 2017 Sep; 8(1):524. PubMed ID: 28900112
[TBL] [Abstract][Full Text] [Related]
18. [Development of TP53-Targeted Treatment in Esophageal Squamous Cell Carcinoma Using Cancer Genomic Profiling Test].
Kamata T; Kano M; Takahashi M; Murakami K; Sakata H; Toyozumi T; Sekino N; Yokoyama M; Okada K; Shiraishi T; Ryuzaki T; Matsubara H
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1608-1610. PubMed ID: 31631150
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Impact of Preoperative Serum Apolipoprotein A-I in Patients with Esophageal Basaloid Squamous Cell Carcinoma.
Feng JF; Zhao JM; Yang X; Wang L
Cancer Manag Res; 2021; 13():7373-7385. PubMed ID: 34588815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
